Article
Ketoamide resistance and hepatitis C virus fitness in val55 variants of the NS3 serine protease.
Antimicrobial agents and chemotherapy - 1 Apr 2012
Welsch Christoph, Schweizer Sabine, Shimakami Tetsuro, Domingues Francisco S, Kim Seungtaek, Lemon Stanley M, Antes Iris
Abstract excerpt
Drug-resistant viral variants are a major issue in the use of direct-acting antiviral agents in chronic hepatitis C. Ketoamides are potent inhibitors of the NS3 protease, with V55A identified as mutation associated with resistance to boceprevir. Underlying molecular mechanisms are only partially understood. We applied a comprehensive sequence analysis to characterize the natural variability at Val55 within...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
